Recherche de variants génomiques en oncologie clinique. Avec des diapos, données & scripts R de: Yannick Boursin, IGR Bastien Job, IGR

Size: px
Start display at page:

Download "Recherche de variants génomiques en oncologie clinique. Avec des diapos, données & scripts R de: Yannick Boursin, IGR Bastien Job, IGR"

Transcription

1 Recherche de variants génomiques en oncologie clinique Avec des diapos, données & scripts R de: Yannick Boursin, IGR Bastien Job, IGR

2 Génétique constitutionnelle At hospital Blood sample Sequence gene panel Look for specific alteration (BRCA) Research Genotype or Sequence Compare disease and healthy cohorts GWAS studies, 1000 Genome Project

3 NGS dans le diagnostic de génétique familiale BRCA1/2 (breast/ovary cancer) XPC, XPV.. (melanoma) ERCC1 (colorectal cancer) 10/19/16 Yannick Boursin 3

4 Génétique somatique Finding somatic mutations in the tumor genome Normal tissue (blood) Tumor tissue Extract and sequence DNA Look for mutations, structural variations Repeat for several patients Look for recurrent events Warning: ,000 SNVs between a tumor and normal tissue from the same person (genome-wide)

5 NGS in precision medicine trials Clinical trials: MOSCATO (GR), SAFIR (GR), SHIVA (Curie), Ipilimumab (anti-ctla4), Nivolumab (anti-pd1), Trastuzumab (anti-her2), Cetuximab (anti-egfr) 10/19/16 Yannick Boursin 5

6 Sequencer quoi? Panel de gènes Une série d exons d intérêt (gènes de cancer= 100kb) Exome Tous les exons du génome (30 Mb) Whole genome Le génome complet (3 Gb)

7 Un pipeline «Variants»

8 Un vrai pipeline «variants» 10 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration

9 FastQC Metrics Look at the different metrics for both reads Problem: the per base sequence quality of the Read2 are quite lowtowards the end Solution: Trim the 25bp from the 3 end of the reads Ø Higher confidence in the sequenced information (FastqTrimmer)

10 Illumina Illumina run C Illumina run C Illumina run D Illumina run D

11 PGM PGM run A PGM run A PGM run B PGM run B

12 Trimming and discarding low quality reads A first Quality Control of raw reads is mandatory and can be established according to the application ('N', adapter sequences, barcode, contamination, etc.) ACTGATTAGTCTGAATTAGANNGATAGGAT GATCGATGCATAGCGATCAGCATCGATACG CGGCGCTCCGCTCTCGAAACTAGCATCGAC ACTGAC AGCATCAGGATCTACGATCTAGCGAACTGAC ACTGAC ACTACTTACGACATCGAGGTTAGGAGCATCA ACTAGGCATCGGCATCACGGACNNNNNNNN ACTAGCTATCGAGCTATCAGCGAGCATCTATC ACTAGCTACTATCGAGCGAGCGATCATCGAC CTGACTACTATCGAGCGAGCTACTAACTGAC ACTGAC ACTATCAGCTAGCGCTTCAGCATTACCGT ACTANNGACTAGGAATTAGCTACTGAGCTAC ACTAGCAGCTATATGAGCTACTAGCACTGAC ACTGAC NNNNNNNNNNNNNNNNNNNNNNNNNNNNN 10/19/16 Yannick Boursin Processed reads: blue parts are to be kept, green and red parts to be 12 removed

13 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration 7-9 AVRIL 2014

14 Alignement des reads sur le génome de référence A G T C Programmes: Bowtie, BWA, Tophat, STAR, HiSat

15 Alignment key parameters - Repeats Approximately 50% of the human genome is comprised of repeats Treangen T.J. and Salzberg S.L Nature review Genetics 13, /19/16 NGS and Bioinformatics Yannick Boursin 15

16 Alignment key parameters Repeats 3 strategies -1- Report only unique alignment -2- Report best alignments and randomly assign reads across equaly good loci -3- Report all (best) alignments A B A B A B Treangen T.J. and Salzberg S.L Nature review Genetics 13, /19/16 Yannick Boursin 16

17 Alignment key parameters Using single or paired-end reads? The type of sequencing (i.e. single or paired-end reads) is often driven by the application. Exemple : Finding large indels, genomic rearrangements,... However, in most cases, the pair information can improve mapping specificity - Single-end alignment repeated sequence A C G A C T C A C G A C T C Reference Genome Sequence A C T A C G A C T C T A C G A G C A T C T A C G A G C T A C T A G C G A T C T A C G A G C T G C G A G C A A C G GC C A A C - Paired-end alignment unique sequence A C G A C T C G G C C A A C A C G A C T C G G C C A A C Reference Genome Sequence A C T A C G A C T C T A C G A G C A T C T A C G A G C T A C T A G C G A T C T A C G A G C T G C G A G C A A C G GC C A A C Yannick Boursin 17

18 Most popular aligners for variant analysis (support mismatched, gapped, paired-end alignment) BWA Li H. and Durbin R. (2009) Bowtie2 Langmead B, Salzberg S (2012)

19 Reads alignés sur le génome

20 Format SAM Contient les séquences alignées sur le génome Dans l idéal : chr ACGTGCGTTTGCGT chr GCGTGATGCGTAAG chr GTATGTTATATGTA

21 Dans la réalité: Format SAM

22 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration 7-9 AVRIL 2014

23 Target intersection Comparer l alignement obtenu à la liste des positions visées par le protocole de capture Exon capturé Alignement non fiable Exon capturé

24 Le variant calling

25 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration 7-9 AVRIL 2014

26 Why realign around indels? Small Insertion/deletion (Indels) in reads (especially near the ends) can trick the mappers into wrong alignments Ø Alignment scoring cheaper to introduce multiple Single Nucleotide Variants (SNVs) than an indel: induce a lot of false positive SNVs èartifactual mismatches Realignment around indels helps improve the downstream processing steps Formation NGS & Cancer - Analyses Exome

27 Local realignment identifies most parsimonious alignment along all reads at problematic loci 1. Find the best alternate consensus sequence that, together with the reference, best fits the reads in a pile 3 adjacent SNPs Realigning determines which is better consistent with the reference consistent with a 3bp insertion 2. The score for an alternate consensus is the total sum of the quality scores of mismatched bases 3. If the score of the best alternate consensus is sufficiently better than the original alignment, then we accept the proposed realignment of the reads Formation NGS & Cancer - Analyses Exome

28 Local realignment around indels Before SNVs After SNVs Deletion Deletion Formation NGS & Cancer - Analyses Exome

29 Local realignment around indels Formation NGS & Cancer - Analyses Exome

30 Local realignment around indels Formation NGS & Cancer - Analyses Exome

31 Three types of realignment targets Indels seen in original alignments (in CIGAR, indicated by I for Insertion or D for Deletion) Sites where evidences suggest a hidden indel (SNV abundance) Known sites: Ø Common polymorphisms: dbsnp, 1000Genomes Formation NGS & Cancer - Analyses Exome

32 Known sites Why are they important? Each tool uses known sites differently, but what is common to all is that they use them to help distinguish true variants from false positives, which is very important to how these tools work. If you don't provide known sites, the statistical analysis of the data will be skewed, which can dramatically affect the sensitivity and reliability of the results. 2. Recommended sets of known sites per tool Formation NGS & Cancer - Analyses Exome

33 Indel realignment steps/tools 1. Identify what regions need to be realigned Ø RealignerTargetCreator + known sites Intervals 2. Perform the actual realignment (BAM output) Ø IndelRealigner Formation NGS & Cancer - Analyses Exome

34 The quality scores issued by sequencers are biased Quality scores are critical for all downstream analysis Systematic biases are a major contributor to bad calls Example of sequence context bias in the reported qualities: before Formation NGS & Cancer - Analyses Exome after

35 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration 7-9 AVRIL 2014

36 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration 7-9 AVRIL 2014

37 Pileup format Describes base-pair information at each position Reference base chr A 108.$,$.,,.,,..,,.,.,..,.,,.,.,,.,..,,..,,.,.,.,.,,.,.,.,,,.,.,.,.,,,.,.,.,.,.,,.,.,.,.,,,,.,,.,.,..,,,,,.,.,,,,^F, Base qualities A 00 chr C 108 Number of reads covering the site (total depth).$t,.,,.t,tt,.,t.,.,t.tttt.ttt,t.t,ttt.tt,t,,.t TtTttt.,.,Tt.ttt.,T,.,.tT,,T,T,.tT,,t,TttTtT,T.,tt,,T,T,tttt^F.^F, Read bases:. /, = match on forward/reverse strand ??6??6 66=????? 6=7??=???<8@7=7=? 77?7?8??78?7????? 8 <8??88 9?8?0048 ACGTN / acgtn = mismatch on forward/reverse strand `-\+[0-9]+[ACGTNacgtn]+ indicates an indel Formation NGS & Cancer - Analyses Exome

38 Analyse du PileUp

39 Analyse du PileUp

40 Analyse du PileUp

41 Depth of Coverage Depth of Coverage = number of reads supporting one position ex: 1X, 5X, 100X... >1000X Reference Base SNV Sequencing Error Reference Genome Aligned Reads 2X 7X 5X brin + 2X brin - 17X 9X brin + 8X brin Calling Confidence +++ NGS - Applications and Analysis 100% = SNV Homozygote 50% 50% = SNV Heterozygote SNV and sequence context (errors) Formation NGS & Cancer - Analyses Exome

42 Variant Calling Factors to consider when calling a SNVs: Base call qualities of each supporting base (base quality) Proximity to small indels, or homopolymer run Mapping qualities of the reads supporting the SNP Sequencing depth: >=30x for constit ; >=100 for tumor SNVs position within the reads: Higher error rate at the reads ends Look at strand bias (SNVs supported by only one strand are more likely to be artifactual) Allelic frequency: Tumor cellularity will reduce the % of an heterozygous variant Higher stringency when calling indels (and sanger validation often needed) Formation NGS & Cancer - Analyses Exome

43 VarScan2 Mutation caller written in Java (no installation required) working with Pileup files of Targeted, Exome, and Whole-Genome sequencing data (DNAseq or RNAseq) Multi-platforms: Illumina, SOLiD, Life/PGM, Roche/454 Detection of different kinds of Germline SNVs/Indels (classical mode): Ø Variants in individual samples Ø Multi-sample variants shared or private in multi-sample datasets VarScan specificity is to be able to work with Tumor/Normal pairs (somatic mode): Ø Somatic and germline mutation, LOH events in tumor-normal pairs Ø Somaticcopy number alterations (CNAs) in tumor-normal exome data Formation NGS & Cancer - Analyses Exome

44 VarScan2 Most published variant callers use Bayesian statistics (a probabilistic framework) to detect variants and assess confidence in them (e.g.: GATK) VarScan uses a robust heuristic/statistic approach to call variants that meet desired thresholds for read depth, base quality, variant allele frequency, and statistical significance Stead et al. (2013) compared 3 different somatic callers : MuTect, Strelka, VarScan2 Ø VarScan2 performed best overall with sequencing depths of 100x, 250x, 500x and 1000x required to accuratelyidentify variants present at 10%, 5%, 2.5% and 1% respectively Formation NGS & Cancer - Analyses Exome

45 Somatic calling

46 Un variant tumoral: polymorphisme ou mutation?

47 Un polymorphisme «normal» (SNP) GERMLINE TISSUE TUMORAL TISSUE

48 Une mutation somatique GERMLINE TISSUE TUMORAL TISSUE

49 Varscan s Somatic P-value Variant Calling and Comparison At every position where both normal and tumor have sufficient coverage, a comparison is made. First, normal and tumor are called independently using the germline consensus calling functionality. Then, their genotypes are compared by the following algorithm: If tumor does not match normal: Calculate significance of allele frequency difference by Fisher's Exact Test If difference is significant (p-value < threshold): If normal matches reference ==> Call Somatic Else If normal is heterozygous ==> Call LOH Else normal and tumor are variant, but different ==> Call IndelFilter or Unknown If difference is not significant: Combined tumor and normal read counts for each allele. Recalculate p-value. ==> Call Germline

50 Format VCF

51 VarScan Tabulated Format Chrom Position Ref Cons Reads1 Reads2 VarFreq Strands Strands 1 2 Qual1 Qual2 Pvalue Map Qual1 Map Qual2 R1 + R1 - R2 + Rs2 - chr C Y % T chr G R % A chr G A % A chr G A % A Alt Cons : Consensus Genotype of Variant Called (IUPAC code): M -> A or C Y -> C or T D -> A or G or T W -> A or T V -> A or C or G R -> A or G K -> G or T B -> C or G or T S -> C or G H -> A or C or T Formation NGS & Cancer - Analyses Exome

52 Reads (Fastq) Reference genome (Fasta) Variant Selection Manual Variant Annotation Anovar Quality Control FastQC Mapping Bowtie2 Variant calling Varscan Somatic Index Samtools Mpileup Target Regions (Bed) Target Intersection Intersect Bam Preprocess #1 GATK local realignment Preprocess #2 GATK QC recalibration 7-9 AVRIL 2014

53 Different types of SNVs SNVs and short indels are the most frequent events: Ø Intergenic Ø Intronic Ø cis-regulatory Ø splice sites Ø frameshift or not Ø synonymous or not Ø benign or damaging etc... Example of SNV one want to pinpoint: Ø non-synonymous + highly deleterious + somatically acquired Formation NGS & Cancer - Analyses Exome

54 Resources dedicated to human genetic variations dbsnp and 1000-genomes Ø Population-scale DNA polymorphisms COSMIC Ø Catalogue Of Somatic Mutations In Cancer Non synonymous SNVs predictions Ø SIFT, Polyphen2 (damaging impact)... PhyloP, GERP++ (conservation) ANNOVAR Tools to annotate genetic variations Formation NGS & Cancer - Analyses Exome

55 Annovar «Annovar» annotates SNVs and Indels Takes Multi sample VCF (Tumor &+normal samples) Ø RefGene: Gene & Function & AminoAcid Change (HGVS format: c.a155g ; p.lys45arg) Ø 1000g2012apr_all: Minor Allele Frequency for all ethnies Ø ESP6500: Exome Sequencing Project Ø Ljb_all : predictions (SIFT, Polyphen2, LRT, MutationTaster, PhyloP, GERP++) ² Tabulated file Formation NGS & Cancer - Analyses Exome

56 Ng & Henikoff, Genome Res Utilise la conservation des domaines protéiques comme indication du caractère délétère d une substitution Classe en D(eleterious), T(olerant),.(unknown) effet réél: LacI

57 PolyPhen2 Adzhubei et al. Nature Methods Probabilistic classifier: Estimates the probability of the missense mutation being damaging based on a combination of seq+struct properties. Classe en: Benign, Possibly damaging, or probably Damaging

58 Coverage & Allelic Frequencies For CNV detection

59 Detection of copy-number variations Are there any copy-numberalteration (gain or lossof chomosomal regions, amplifications ) that could explain tumorigenesis? Yannick Boursin 59

60 La fraction allélique Vocabulaire: Germline/population: Allelic frequency, MAF (minor allele frequency). Par ex. dans données 1000Genomes. Somatic: Allelic fraction (mais souvent on utilise VAF or BAF: variant allele frequency) Où trouver l info? Colonne info#af dans VCF 10/19/16 Yannick Boursin 60

61 BAF Cellularité et Fréquence Allelique

62 Segmentation et fréquence allélique BAF Rratio R ratio=utilisé en CGH, =couverture en NGS Scott et al. Gene 2014

63 Les «signatures d Alexandrov» Yannick Boursin L. Alexandrov M Stratton, Nature

64 Signatures et origine des tumeurs 10/19/16 Yannick Boursin 64 L. Alexandrov M Stratton, Nature 201

65 Données exercice Données de cancer ovarien WES Normal + tumeur Original BAM: 10Go 2 fichiers tabulés: tumor-xxx : Tous les variants de la tumeur (somatique ou non) som-xxx : Les variants déclarés somatiques (par comparaison avec normal) et annotés Pipeline: Alignement bwa Post traitement bam picardtools sortsam GATK indelrealigner GATK variantrecalibration Variant Calling samtools mpileup varscan2 somatic Filtering variants somatiques ou LOH & Somatic P-value < 10^-3 Annotation SNPeff, SNPSIFT Script VCF>Tabulé

66 Fichier «questions» Atelier pratique

DNA-seq Bioinformatics Analysis: Copy Number Variation

DNA-seq Bioinformatics Analysis: Copy Number Variation DNA-seq Bioinformatics Analysis: Copy Number Variation Elodie Girard elodie.girard@curie.fr U900 institut Curie, INSERM, Mines ParisTech, PSL Research University Paris, France NGS Applications 5C HiC DNA-seq

More information

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research

Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,

More information

NGS, Cancer and Bioinforma;cs. 20/10/15 Yannick Boursin

NGS, Cancer and Bioinforma;cs. 20/10/15 Yannick Boursin NGS, Cancer and Bioinforma;cs 1 NGS and Clinical Oncology NGS in hereditary cancer genome tes;ng BRCA1/2 (breast/ovary cancer) XPC (melanoma) ERCC1 (colorectal cancer) NGS for personalized cancer treatment

More information

Golden Helix s End-to-End Solution for Clinical Labs

Golden Helix s End-to-End Solution for Clinical Labs Golden Helix s End-to-End Solution for Clinical Labs Steven Hystad - Field Application Scientist Nathan Fortier Senior Software Engineer 20 most promising Biotech Technology Providers Top 10 Analytics

More information

Supplementary Methods

Supplementary Methods Supplementary Methods Short Read Preprocessing Reads are preprocessed differently according to how they will be used: detection of the variant in the tumor, discovery of an artifact in the normal or for

More information

Analysis with SureCall 2.1

Analysis with SureCall 2.1 Analysis with SureCall 2.1 Danielle Fletcher Field Application Scientist July 2014 1 Stages of NGS Analysis Primary analysis, base calling Control Software FASTQ file reads + quality 2 Stages of NGS Analysis

More information

Supplementary Figure 1. Estimation of tumour content

Supplementary Figure 1. Estimation of tumour content Supplementary Figure 1. Estimation of tumour content a, Approach used to estimate the tumour content in S13T1/T2, S6T1/T2, S3T1/T2 and S12T1/T2. Tissue and tumour areas were evaluated by two independent

More information

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction

Abstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant

More information

Identifying Mutations Responsible for Rare Disorders Using New Technologies

Identifying Mutations Responsible for Rare Disorders Using New Technologies Identifying Mutations Responsible for Rare Disorders Using New Technologies Jacek Majewski, Department of Human Genetics, McGill University, Montreal, QC Canada Mendelian Diseases Clear mode of inheritance

More information

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies

More information

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute

Whole Genome and Transcriptome Analysis of Anaplastic Meningioma. Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Whole Genome and Transcriptome Analysis of Anaplastic Meningioma Patrick Tarpey Cancer Genome Project Wellcome Trust Sanger Institute Outline Anaplastic meningioma compared to other cancers Whole genomes

More information

6/12/2018. Disclosures. Clinical Genomics The CLIA Lab Perspective. Outline. COH HopeSeq Heme Panels

6/12/2018. Disclosures. Clinical Genomics The CLIA Lab Perspective. Outline. COH HopeSeq Heme Panels Clinical Genomics The CLIA Lab Perspective Disclosures Raju K. Pillai, M.D. Hematopathologist / Molecular Pathologist Director, Pathology Bioinformatics City of Hope National Medical Center, Duarte, CA

More information

WHOLE EXOME SEQUENCING PIPELINE EVALUATION AND MUTATION DETECTION IN ESOPHAGEAL CANCER PATIENTS

WHOLE EXOME SEQUENCING PIPELINE EVALUATION AND MUTATION DETECTION IN ESOPHAGEAL CANCER PATIENTS WHOLE EXOME SEQUENCING PIPELINE EVALUATION AND MUTATION DETECTION IN ESOPHAGEAL CANCER PATIENTS SUMMARY Tran Thi Bich Ngoc 1 ; Ho Viet Hoanh 2 ; Vu Phuong Nhung 1 ; Nguyen Hai Ha 1 Nguyen Van Ba 2 ; Nguyen

More information

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS

Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS Breast and ovarian cancer in Serbia: the importance of mutation detection in hereditary predisposition genes using NGS dr sc. Ana Krivokuća Laboratory for molecular genetics Institute for Oncology and

More information

Supplementary Information

Supplementary Information 1 Supplementary Information MATERIALS AND METHODS Study subjects Exome-sequenced HBOC patients Clinical characteristics of 24 exome-sequenced HBOC patients are presented in Table 1. Table 1. Clinical characteristics

More information

Frequency(%) KRAS G12 KRAS G13 KRAS A146 KRAS Q61 KRAS K117N PIK3CA H1047 PIK3CA E545 PIK3CA E542K PIK3CA Q546. EGFR exon19 NFS-indel EGFR L858R

Frequency(%) KRAS G12 KRAS G13 KRAS A146 KRAS Q61 KRAS K117N PIK3CA H1047 PIK3CA E545 PIK3CA E542K PIK3CA Q546. EGFR exon19 NFS-indel EGFR L858R Frequency(%) 1 a b ALK FS-indel ALK R1Q HRAS Q61R HRAS G13R IDH R17K IDH R14Q MET exon14 SS-indel KIT D8Y KIT L76P KIT exon11 NFS-indel SMAD4 R361 IDH1 R13 CTNNB1 S37 CTNNB1 S4 AKT1 E17K ERBB D769H ERBB

More information

CHR POS REF OBS ALLELE BUILD CLINICAL_SIGNIFICANCE

CHR POS REF OBS ALLELE BUILD CLINICAL_SIGNIFICANCE CHR POS REF OBS ALLELE BUILD CLINICAL_SIGNIFICANCE is_clinical dbsnp MITO GENE chr1 13273 G C heterozygous - - -. - DDX11L1 chr1 949654 A G Homozygous 52 - - rs8997 - ISG15 chr1 1021346 A G heterozygous

More information

PSSV User Manual (V1.0)

PSSV User Manual (V1.0) PSSV User Manual (V1.0) 1. Introduction A novel pattern-based probabilistic approach, PSSV, is developed to identify somatic structural variations from WGS data. Specifically, discordant and concordant

More information

AACR GENIE Data Guide

AACR GENIE Data Guide AACR GENIE Data Guide About this Document Version of Data Data Access Terms of Access Introduction to AACR GENIE Human Subjects Protection and Privacy Summary of Data by Center Genomic Profiling at Each

More information

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits

AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect

More information

Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Complete Genomics, Inc.

Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Complete Genomics, Inc. Dr Rick Tearle Senior Applications Specialist, EMEA Complete Genomics Topics Overview of Data Processing Pipeline Overview of Data Files 2 DNA Nano-Ball (DNB) Read Structure Genome : acgtacatgcattcacacatgcttagctatctctcgccag

More information

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library

Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Marilou Wijdicks International Product Manager Research For Life Science Research Only. Not for Use in Diagnostic Procedures.

More information

CITATION FILE CONTENT/FORMAT

CITATION FILE CONTENT/FORMAT CITATION For any resultant publications using please cite: Matthew A. Field, Vicky Cho, T. Daniel Andrews, and Chris C. Goodnow (2015). "Reliably detecting clinically important variants requires both combined

More information

Reporting TP53 gene analysis results in CLL

Reporting TP53 gene analysis results in CLL Reporting TP53 gene analysis results in CLL Mutations in TP53 - From discovery to clinical practice in CLL Discovery Validation Clinical practice Variant diversity *Leroy at al, Cancer Research Review

More information

ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics

ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics ACE ImmunoID Biomarker Discovery Solutions ACE ImmunoID Platform for Tumor Immunogenomics Precision Genomics for Immuno-Oncology Personalis, Inc. ACE ImmunoID When one biomarker doesn t tell the whole

More information

Genome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl.

Genome. Institute. GenomeVIP: A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud. R. Jay Mashl. GenomeVIP: the Genome Institute at Washington University A Genomics Analysis Pipeline for Cloud Computing with Germline and Somatic Calling on Amazon s Cloud R. Jay Mashl October 20, 2014 Turnkey Variant

More information

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc.

Variant Classification. Author: Mike Thiesen, Golden Helix, Inc. Variant Classification Author: Mike Thiesen, Golden Helix, Inc. Overview Sequencing pipelines are able to identify rare variants not found in catalogs such as dbsnp. As a result, variants in these datasets

More information

Identification of genomic alterations in cervical cancer biopsies by exome sequencing

Identification of genomic alterations in cervical cancer biopsies by exome sequencing Chapter- 4 Identification of genomic alterations in cervical cancer biopsies by exome sequencing 105 4.1 INTRODUCTION Athough HPV has been identified as the prime etiological factor for cervical cancer,

More information

ISOWN: accurate somatic mutation identification in the absence of normal tissue controls

ISOWN: accurate somatic mutation identification in the absence of normal tissue controls Kalatskaya et al. Genome Medicine (2017) 9:59 DOI 10.1186/s13073-017-0446-9 SOFTWARE ISOWN: accurate somatic mutation identification in the absence of normal tissue controls Irina Kalatskaya 1*, Quang

More information

P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University.

P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University. Databases and Tools for High Throughput Sequencing Analysis P. Tang ( 鄧致剛 ); PJ Huang ( 黄栢榕 ) g( ); g ( ) Bioinformatics Center, Chang Gung University. HTseq Platforms Applications on Biomedical Sciences

More information

VARIANT PRIORIZATION AND ANALYSIS INCORPORATING PROBLEMATIC REGIONS OF THE GENOME ANIL PATWARDHAN

VARIANT PRIORIZATION AND ANALYSIS INCORPORATING PROBLEMATIC REGIONS OF THE GENOME ANIL PATWARDHAN VARIANT PRIORIZATION AND ANALYSIS INCORPORATING PROBLEMATIC REGIONS OF THE GENOME ANIL PATWARDHAN Email: apatwardhan@personalis.com MICHAEL CLARK Email: michael.clark@personalis.com ALEX MORGAN Email:

More information

Figure S4. 15 Mets Whole Exome. 5 Primary Tumors Cancer Panel and WES. Next Generation Sequencing

Figure S4. 15 Mets Whole Exome. 5 Primary Tumors Cancer Panel and WES. Next Generation Sequencing Figure S4 Next Generation Sequencing 15 Mets Whole Exome 5 Primary Tumors Cancer Panel and WES Get coverage of all variant loci for all three Mets Variant Filtering Sequence Alignments Index and align

More information

AACR GENIE Data Guide

AACR GENIE Data Guide AACR GENIE Data Guide About this Document Version of Data Data Access Terms of Access Introduction to AACR GENIE Human Subjects Protection and Privacy Summary of Data by Center Genomic Profiling at Each

More information

Performance Characteristics BRCA MASTR Plus Dx

Performance Characteristics BRCA MASTR Plus Dx Performance Characteristics BRCA MASTR Plus Dx with drmid Dx for Illumina NGS systems Manufacturer Multiplicom N.V. Galileïlaan 18 2845 Niel Belgium Table of Contents 1. Workflow... 4 2. Performance Characteristics

More information

ACE ImmunoID. ACE ImmunoID. Precision immunogenomics. Precision Genomics for Immuno-Oncology

ACE ImmunoID. ACE ImmunoID. Precision immunogenomics. Precision Genomics for Immuno-Oncology ACE ImmunoID ACE ImmunoID Precision immunogenomics Precision Genomics for Immuno-Oncology Personalis, Inc. A universal biomarker platform for immuno-oncology Patient response to cancer immunotherapies

More information

Illuminating the genetics of complex human diseases

Illuminating the genetics of complex human diseases Illuminating the genetics of complex human diseases Michael Schatz Sept 27, 2012 Beyond the Genome @mike_schatz / #BTG2012 Outline 1. De novo mutations in human diseases 1. Autism Spectrum Disorder 2.

More information

Below, we included the point-to-point response to the comments of both reviewers.

Below, we included the point-to-point response to the comments of both reviewers. To the Editor and Reviewers: We would like to thank the editor and reviewers for careful reading, and constructive suggestions for our manuscript. According to comments from both reviewers, we have comprehensively

More information

Variant Annotation and Functional Prediction

Variant Annotation and Functional Prediction Variant Annotation and Functional Prediction Copyrighted 2018 Isabelle Schrauwen and Suzanne M. Leal This exercise touches on several functionalities of the program ANNOVAR to annotate and interpret candidate

More information

Tumor mutational burden and its transition towards the clinic

Tumor mutational burden and its transition towards the clinic Tumor mutational burden and its transition towards the clinic G C C A T C A C Wolfram Jochum Institute of Pathology Kantonsspital St.Gallen CH-9007 St.Gallen wolfram.jochum@kssg.ch 30th European Congress

More information

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB

AVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation

More information

BWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space

BWA alignment to reference transcriptome and genome. Convert transcriptome mappings back to genome space Whole genome sequencing Whole exome sequencing BWA alignment to reference transcriptome and genome Convert transcriptome mappings back to genome space genomes Filter on MQ, distance, Cigar string Annotate

More information

Nature Biotechnology: doi: /nbt.1904

Nature Biotechnology: doi: /nbt.1904 Supplementary Information Comparison between assembly-based SV calls and array CGH results Genome-wide array assessment of copy number changes, such as array comparative genomic hybridization (acgh), is

More information

NGS in tissue and liquid biopsy

NGS in tissue and liquid biopsy NGS in tissue and liquid biopsy Ana Vivancos, PhD Referencias So, why NGS in the clinics? 2000 Sanger Sequencing (1977-) 2016 NGS (2006-) ABIPrism (Applied Biosystems) Up to 2304 per day (96 sequences

More information

TOWARDS ACCURATE GERMLINE AND SOMATIC INDEL DISCOVERY WITH MICRO-ASSEMBLY. Giuseppe Narzisi, PhD Bioinformatics Scientist

TOWARDS ACCURATE GERMLINE AND SOMATIC INDEL DISCOVERY WITH MICRO-ASSEMBLY. Giuseppe Narzisi, PhD Bioinformatics Scientist TOWARDS ACCURATE GERMLINE AND SOMATIC INDEL DISCOVERY WITH MICRO-ASSEMBLY Giuseppe Narzisi, PhD Bioinformatics Scientist July 29, 2014 Micro-Assembly Approach to detect INDELs 2 Outline 1 Detecting INDELs:

More information

Investigating rare diseases with Agilent NGS solutions

Investigating rare diseases with Agilent NGS solutions Investigating rare diseases with Agilent NGS solutions Chitra Kotwaliwale, Ph.D. 1 Rare diseases affect 350 million people worldwide 7,000 rare diseases 80% are genetic 60 million affected in the US, Europe

More information

Transform genomic data into real-life results

Transform genomic data into real-life results CLINICAL SUMMARY Transform genomic data into real-life results Biomarker testing and targeted therapies can drive improved outcomes in clinical practice New FDA-Approved Broad Companion Diagnostic for

More information

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing

Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Karl V. Voelkerding, MD Professor of Pathology University of Utah Medical

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

Home Brewed Personalized Genomics

Home Brewed Personalized Genomics Home Brewed Personalized Genomics The Quest for Meaningful Analysis Results of a 23andMe Exome Pilot Trio of Myself, Wife, and Son February 22, 2013 Gabe Rudy, Vice President of Product Development Exome

More information

ChIP-seq hands-on. Iros Barozzi, Campus IFOM-IEO (Milan) Saverio Minucci, Gioacchino Natoli Labs

ChIP-seq hands-on. Iros Barozzi, Campus IFOM-IEO (Milan) Saverio Minucci, Gioacchino Natoli Labs ChIP-seq hands-on Iros Barozzi, Campus IFOM-IEO (Milan) Saverio Minucci, Gioacchino Natoli Labs Main goals Becoming familiar with essential tools and formats Visualizing and contextualizing raw data Understand

More information

Cancer Gene Panels. Dr. Andreas Scherer. Dr. Andreas Scherer President and CEO Golden Helix, Inc. Twitter: andreasscherer

Cancer Gene Panels. Dr. Andreas Scherer. Dr. Andreas Scherer President and CEO Golden Helix, Inc. Twitter: andreasscherer Cancer Gene Panels Dr. Andreas Scherer Dr. Andreas Scherer President and CEO Golden Helix, Inc. scherer@goldenhelix.com Twitter: andreasscherer About Golden Helix - Founded in 1998 - Main outside investor:

More information

An integrated map of genetic variation from 1092 human genomes

An integrated map of genetic variation from 1092 human genomes SUPPLEMENTAL METHODS AND MATERIALS Whole genome sequencing Alignment: Short insert paired-end reads were aligned to the GRCh37 reference human genome with 1000 genomes decoy contigs using BWA-mem(1). Somatic

More information

Comprehensive genomic profiling for various solid tumors

Comprehensive genomic profiling for various solid tumors Content Highlight Test Specification Test Content Performance Validation Test Report I II III IV V The NovoPM TM comprehensive cancer genomic profiling test Comprehensive genomic profiling for various

More information

NGS ONCOPANELS: FDA S PERSPECTIVE

NGS ONCOPANELS: FDA S PERSPECTIVE NGS ONCOPANELS: FDA S PERSPECTIVE CBA Workshop: Biomarker and Application in Drug Development August 11, 2018 Rockville, MD You Li, Ph.D. Division of Molecular Genetics and Pathology Food and Drug Administration

More information

TP53 mutational profile in CLL : A retrospective study of the FILO group.

TP53 mutational profile in CLL : A retrospective study of the FILO group. TP53 mutational profile in CLL : A retrospective study of the FILO group. Fanny Baran-Marszak Hopital Avicenne Bobigny France 2nd ERIC workshop on TP53 analysis in CLL, Stresa 2017 TP53 abnormalities :

More information

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS

Fluxion Biosciences and Swift Biosciences Somatic variant detection from liquid biopsy samples using targeted NGS APPLICATION NOTE Fluxion Biosciences and Swift Biosciences OVERVIEW This application note describes a robust method for detecting somatic mutations from liquid biopsy samples by combining circulating tumor

More information

Calling DNA variants SNVs, CNVs, and SVs. Steve Laurie Variant Effect Predictor Training Course Prague, 6 th November 2017

Calling DNA variants SNVs, CNVs, and SVs. Steve Laurie Variant Effect Predictor Training Course Prague, 6 th November 2017 1 Calling DNA variants SNVs, CNVs, and SVs Steve Laurie Variant Effect Predictor Training Course Prague, 6 th November 2017 Calling DNA variants SNVs, CNVs, SVs 2 1. What is a variant? 2. Paired End read

More information

Global assessment of genomic variation in cattle by genome resequencing and high-throughput genotyping

Global assessment of genomic variation in cattle by genome resequencing and high-throughput genotyping RESEARCH ARTICLE Open Access Global assessment of genomic variation in cattle by genome resequencing and high-throughput genotyping Bujie Zhan 1, João Fadista 1, Bo Thomsen 1, Jakob Hedegaard 1,2, Frank

More information

DNA Sequence Bioinformatics Analysis with the Galaxy Platform

DNA Sequence Bioinformatics Analysis with the Galaxy Platform DNA Sequence Bioinformatics Analysis with the Galaxy Platform University of São Paulo, Brazil 28 July - 1 August 2014 Dave Clements Johns Hopkins University Robson Francisco de Souza University of São

More information

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT

Genetic Testing and Analysis. (858) MRN: Specimen: Saliva Received: 07/26/2016 GENETIC ANALYSIS REPORT GBinsight Sample Name: GB4411 Race: Gender: Female Reason for Testing: Type 2 diabetes, early onset MRN: 0123456789 Specimen: Saliva Received: 07/26/2016 Test ID: 113-1487118782-4 Test: Type 2 Diabetes

More information

Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep

Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep Tom Walsh, PhD Division of Medical Genetics University of Washington Next generation sequencing Sanger sequencing gold

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Systematic investigation of cancer-associated somatic point mutations in SNP databases HyunChul Jung 1,2, Thomas Bleazard 3, Jongkeun Lee 1 and Dongwan Hong 1 1. Cancer Genomics

More information

New Enhancements: GWAS Workflows with SVS

New Enhancements: GWAS Workflows with SVS New Enhancements: GWAS Workflows with SVS August 9 th, 2017 Gabe Rudy VP Product & Engineering 20 most promising Biotech Technology Providers Top 10 Analytics Solution Providers Hype Cycle for Life sciences

More information

Research Strategy: 1. Background and Significance

Research Strategy: 1. Background and Significance Research Strategy: 1. Background and Significance 1.1. Heterogeneity is a common feature of cancer. A better understanding of this heterogeneity may present therapeutic opportunities: Intratumor heterogeneity

More information

Identification of Genetic Determinants of Metastasis and Clonal Relationships Between Primary and Metastatic Tumors

Identification of Genetic Determinants of Metastasis and Clonal Relationships Between Primary and Metastatic Tumors Washington University in St. Louis Washington University Open Scholarship All Theses and Dissertations (ETDs) Spring 5-1-2013 Identification of Genetic Determinants of Metastasis and Clonal Relationships

More information

Copy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015

Copy Number Varia/on Detec/on. Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015 Copy Number Varia/on Detec/on Alex Mawla UCD Genome Center Bioinforma5cs Core Tuesday June 16, 2015 Today s Goals Understand the applica5on and capabili5es of using targe5ng sequencing and CNV calling

More information

Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection

Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection Dr Elaine Kenny Neuropsychiatric Genetics Research Group Institute of Molecular Medicine Trinity College Dublin

More information

Genomic structural variation

Genomic structural variation Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural

More information

Supplementary Figure 1: Classification scheme for non-synonymous and nonsense germline MC1R variants. The common variants with previously established

Supplementary Figure 1: Classification scheme for non-synonymous and nonsense germline MC1R variants. The common variants with previously established Supplementary Figure 1: Classification scheme for nonsynonymous and nonsense germline MC1R variants. The common variants with previously established classifications 1 3 are shown. The effect of novel missense

More information

PSSV User Manual (V2.1)

PSSV User Manual (V2.1) PSSV User Manual (V2.1) 1. Introduction A novel pattern-based probabilistic approach, PSSV, is developed to identify somatic structural variations from WGS data. Specifically, discordant and concordant

More information

Molecular Characterization of Tumors Using Next-Generation Sequencing

Molecular Characterization of Tumors Using Next-Generation Sequencing Molecular Characterization of Tumors Using Next-Generation Sequencing Using BaseSpace to visualize molecular changes in cancer. Tumor-Normal Sequencing Data in BaseSpace To enable researchers new to next-generation

More information

Transcriptome Analysis

Transcriptome Analysis Transcriptome Analysis Data Preprocessing Sample Preparation Illumina Sequencing Demultiplexing Raw FastQ Reference Genome (fasta) Reference Annotation (GTF) Reference Genome Analysis Tophat Accepted hits

More information

The$mitochondrial$and$autosomal$mutation$landscapes$of$ prostate$cancer$ $supplementary$material$

The$mitochondrial$and$autosomal$mutation$landscapes$of$ prostate$cancer$ $supplementary$material$ The$mitochondrial$and$autosomal$mutation$landscapes$of$ prostate$cancer$ $supplementary$material$ Johan Lindberg 1, Ian G. Mills 2-4, Daniel Klevebring 1, Wennuan Liu 5, Mårten Neiman 1, Jianfeng Xu 5,

More information

SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab

SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA. Giuseppe Narzisi, PhD Schatz Lab SCALPEL MICRO-ASSEMBLY APPROACH TO DETECT INDELS WITHIN EXOME-CAPTURE DATA Giuseppe Narzisi, PhD Schatz Lab November 14, 2013 Micro-Assembly Approach to detect INDELs 2 Outline Scalpel micro-assembly pipeline

More information

AD (Leave blank) TITLE: Genomic Characterization of Brain Metastasis in Non-Small Cell Lung Cancer Patients

AD (Leave blank) TITLE: Genomic Characterization of Brain Metastasis in Non-Small Cell Lung Cancer Patients AD (Leave blank) Award Number: W81XWH-12-1-0444 TITLE: Genomic Characterization of Brain Metastasis in Non-Small Cell Lung Cancer Patients PRINCIPAL INVESTIGATOR: Mark A. Watson, MD PhD CONTRACTING ORGANIZATION:

More information

Functional analysis of DNA variants

Functional analysis of DNA variants Functional analysis of DNA variants GS011143, Introduction to Bioinformatics The University of Texas GSBS program, Fall 2012 Ken Chen, Ph.D. Department of Bioinformatics and Computational Biology UT MD

More information

Variant Detection & Interpretation in a diagnostic context. Christian Gilissen

Variant Detection & Interpretation in a diagnostic context. Christian Gilissen Variant Detection & Interpretation in a diagnostic context Christian Gilissen c.gilissen@gen.umcn.nl 28-05-2013 So far Sequencing Johan den Dunnen Marja Jakobs Ewart de Bruijn Mapping Victor Guryev Variant

More information

No mutations were identified.

No mutations were identified. Hereditary High Cholesterol Test ORDERING PHYSICIAN PRIMARY CONTACT SPECIMEN Report date: Aug 1, 2017 Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA Kelly Peters Sample Medical Group 123

More information

RNA SEQUENCING AND DATA ANALYSIS

RNA SEQUENCING AND DATA ANALYSIS RNA SEQUENCING AND DATA ANALYSIS Length of mrna transcripts in the human genome 5,000 5,000 4,000 3,000 2,000 4,000 1,000 0 0 200 400 600 800 3,000 2,000 1,000 0 0 2,000 4,000 6,000 8,000 10,000 Length

More information

EXAMPLE. - Potentially responsive to PI3K/mTOR and MEK combination therapy or mtor/mek and PKC combination therapy. ratio (%)

EXAMPLE. - Potentially responsive to PI3K/mTOR and MEK combination therapy or mtor/mek and PKC combination therapy. ratio (%) Dr Kate Goodhealth Goodhealth Medical Clinic 123 Address Road SUBURBTOWN NSW 2000 Melanie Citizen Referring Doctor Your ref Address Dr John Medico 123 Main Street, SUBURBTOWN NSW 2000 Phone 02 9999 9999

More information

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST

PERSONALIZED GENETIC REPORT CLIENT-REPORTED DATA PURPOSE OF THE X-SCREEN TEST INCLUDED IN THIS REPORT: REVIEW OF YOUR GENETIC INFORMATION RELEVANT TO ENDOMETRIOSIS PERSONAL EDUCATIONAL INFORMATION RELEVANT TO YOUR GENES INFORMATION FOR OBTAINING YOUR ENTIRE X-SCREEN DATA FILE PERSONALIZED

More information

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies

Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these

More information

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser

Characterisation of structural variation in breast. cancer genomes using paired-end sequencing on. the Illumina Genome Analyser Characterisation of structural variation in breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser Phil Stephens Cancer Genome Project Why is it important to study cancer? Why

More information

NGS IN ONCOLOGY: FDA S PERSPECTIVE

NGS IN ONCOLOGY: FDA S PERSPECTIVE NGS IN ONCOLOGY: FDA S PERSPECTIVE ASQ Biomed/Biotech SIG Event April 26, 2018 Gaithersburg, MD You Li, Ph.D. Division of Molecular Genetics and Pathology Food and Drug Administration (FDA) Center for

More information

CRISPR/Cas9 Enrichment and Long-read WGS for Structural Variant Discovery

CRISPR/Cas9 Enrichment and Long-read WGS for Structural Variant Discovery CRISPR/Cas9 Enrichment and Long-read WGS for Structural Variant Discovery PacBio CoLab Session October 20, 2017 For Research Use Only. Not for use in diagnostics procedures. Copyright 2017 by Pacific Biosciences

More information

ChIP-seq data analysis

ChIP-seq data analysis ChIP-seq data analysis Harri Lähdesmäki Department of Computer Science Aalto University November 24, 2017 Contents Background ChIP-seq protocol ChIP-seq data analysis Transcriptional regulation Transcriptional

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature11396 A total of 2078 samples from a large sequencing project at decode were used in this study, 219 samples from 78 trios with two grandchildren who were not also members of other trios,

More information

LEIDEN, THE NETHERLANDS

LEIDEN, THE NETHERLANDS Full-length CYP2D6 diplotyping for better drug dosage and response management Henk Buermans, PhD Leiden University Medical Center Human Genetics, LGTC LEIDEN, THE NETHERLANDS CYP2D6 Function Metabolism

More information

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC.

Nature Genetics: doi: /ng Supplementary Figure 1. Rates of different mutation types in CRC. Supplementary Figure 1 Rates of different mutation types in CRC. (a) Stratification by mutation type indicates that C>T mutations occur at a significantly greater rate than other types. (b) As for the

More information

SVIM: Structural variant identification with long reads DAVID HELLER MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS, BERLIN JUNE 2O18, SMRT LEIDEN

SVIM: Structural variant identification with long reads DAVID HELLER MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS, BERLIN JUNE 2O18, SMRT LEIDEN SVIM: Structural variant identification with long reads DAVID HELLER MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS, BERLIN JUNE 2O18, SMRT LEIDEN Structural variation (SV) Variants larger than 50bps Affect

More information

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2

Andrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2 METHOD ARTICLE An enhanced method for targeted next generation sequencing copy number variant detection using ExomeDepth [version 1; referees: 1 approved, 1 approved with reservations] 1 2 1 3,4 Andrew

More information

Supplementary Material for IPred - Integrating Ab Initio and Evidence Based Gene Predictions to Improve Prediction Accuracy

Supplementary Material for IPred - Integrating Ab Initio and Evidence Based Gene Predictions to Improve Prediction Accuracy 1 SYSTEM REQUIREMENTS 1 Supplementary Material for IPred - Integrating Ab Initio and Evidence Based Gene Predictions to Improve Prediction Accuracy Franziska Zickmann and Bernhard Y. Renard Research Group

More information

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer

Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer www.impactjournals.com/oncotarget/ Oncotarget, Supplementary Materials 2016 Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer Supplementary Materials Supplementary

More information

Supplementary Materials for

Supplementary Materials for www.sciencetranslationalmedicine.org/cgi/content/full/7/283/283ra54/dc1 Supplementary Materials for Clonal status of actionable driver events and the timing of mutational processes in cancer evolution

More information

Rare Variant Burden Tests. Biostatistics 666

Rare Variant Burden Tests. Biostatistics 666 Rare Variant Burden Tests Biostatistics 666 Last Lecture Analysis of Short Read Sequence Data Low pass sequencing approaches Modeling haplotype sharing between individuals allows accurate variant calls

More information

Supplementary Tables. Supplementary Figures

Supplementary Tables. Supplementary Figures Supplementary Files for Zehir, Benayed et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients Supplementary Tables Supplementary Table 1: Sample

More information

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY More genetic information requires cutting-edge interpretation techniques Whole Exome Sequencing For certain patients the combination of symptoms does not allow

More information

!"##"$%#"&!'&$'()$(%&'*& Terapia Pediatrica e Farmacologia dello Sviluppo +,-./&01,23&34,53& :&;.<&2-.=;:3&;.;2>6-6&-.&;&

!##$%#&!'&$'()$(%&'*& Terapia Pediatrica e Farmacologia dello Sviluppo +,-./&01,23&34,53& :&;.<&2-.=;:3&;.;2>6-6&-.&;& !!! "#$%&'($)*!+&,-$!.)/+$!+$!01,-$1'$!!"##"$%#"&!'&$'()$(%&'*& Terapia Pediatrica e Farmacologia dello Sviluppo 0$2-3!44566!! +,-./&01,23&34,53&63783.9-.:&;.6-6&-.&;& 582/-:3.3?;/-,.;2&@;5-2>&63:?3:;/-.:&#>A3&B&!-;C3/36&!.&))3'&!(2$&#)$7$23!+$(2$8-$#1'&!+$!177&'&#91!!

More information

Session 4 Rebecca Poulos

Session 4 Rebecca Poulos The Cancer Genome Atlas (TCGA) & International Cancer Genome Consortium (ICGC) Session 4 Rebecca Poulos Prince of Wales Clinical School Introductory bioinformatics for human genomics workshop, UNSW 20

More information

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY

CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY More genetic information requires cutting-edge interpretation techniques Whole Exome Sequencing For some patients, the combination of symptoms does not allow

More information